Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1a Study of Telpegfilgrastim in Non-pregnant Women of Childbearing Age
NCT06924385Phase 1Completed
- Sponsor
- Xiamen Tebao Biological Engineering Co., Ltd.
- Start
- Apr 2025
- Primary completion
- Jan 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label trial of pegfilgrastim in preeclampsia (5 cohorts), sponsored by Xiamen Tebao Biological Engineering Co., Ltd. Primary endpoints: Adverse Events, Respiration Rate and 18 more. Started Apr 2025; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT06924385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06924385.